Market Overview:
The global biotechnology/pharmaceutical services outsourcing market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for outsourcing services by biotechnology and pharmaceutical companies, rising focus on cost-effective solutions, and the growing need for specialized services. The consulting segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing demand for consulting services by biotechnology and pharmaceutical companies due to their growing complexity and globalization. The regenerative medicine segment is expected to grow at the highest CAGR during the forecast period owing to its high potential in curing various diseases such as cancer, diabetes, heart diseases, and others.
Product Definition:
Biotechnology/pharmaceutical services outsourcing is the contracting of specific biotechnological or pharmaceutical processes, operations, or services to a third party. The importance of biotechnology/pharmaceutical services outsourcing lies in the ability to outsource certain functions that a company may not have the resources or expertise to perform in-house. This can provide significant cost savings and allow companies to focus on their core competencies.
Consulting:
Consulting is a service, which involves advice and expertise of an expert to assist client in achieving their objectives. It can be defined as the provision of knowledge or help by a professional to another professional or layman with specific problems. The main aim of consulting is to enhance efficiency and productivity for both enterprises (consultant & client) involved in the transaction.
Auditing & Assessment:
The global auditing and assessment market size was valued at USD 2.56 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The rising need for an effective internal control system in order to reduce cost, time, and risk has led to the adoption of audit &assessment tools by pharmaceutical companies as well as biotechnology/life science organizations operating across different geographies.
Application Insights:
Regenerative medicine services accounted for the largest revenue share in 2016 and is anticipated to maintain its lead over the forecast period. The segment is driven by increasing demand for stem cell therapies and growing regenerative medicine industry. Regenerative medicines help in healing, prevention, and treatment of chronic diseases through stimulation or inhibition of a cellular response to injury or disease process. These therapies are based on the concept that cells can be stimulated to become healthy tissues instead of unhealthy ones.
Regional Analysis:
The global market is segmented into North America, Europe, Asia Pacific and Middle East & Africa. The North American regional market accounted for the largest revenue share in 2017 owing to the presence of a large number of CROs offering services pertaining to biotechnology and pharmaceuticals. In addition, increasing R&D investments by major companies in this region are driving growth. For instance, according to the National Institute of Health (NIH), in 2016-2017 fiscal year U.S.
Growth Factors:
- Increasing demand for biopharmaceuticals and biosimilars: The global market for biopharmaceuticals is expected to grow at a CAGR of 12.8% from 2016 to 2021, reaching a value of 2.8 billion by 2021. This growth is primarily attributed to the increasing prevalence of chronic diseases, rising awareness about personalized medicines, and technological advancements in the field of biotechnology.
- Growing demand for contract manufacturing services: The contract manufacturing services (CMS) market is projected to grow at a CAGR of 9% from 2016 to 2021, reaching a value of billion by 2021. This growth can be attributed to the increasing number of outsourcing agreements between pharmaceutical companies and contract manufacturers, growing focus on cost-effective production methods, and rising demand for specialty drugs.
- Proliferation of generics: Generic drugs are cheaper alternatives to branded drugs that are approved by regulatory authorities after meeting certain standards with respect to quality, safety, and efficacy profile as compared with their branded counterparts .The global generic drug market is expected grow at a CAGRof 6% from 2016-2021and reach USD9billionby 2021 .Thisgrowthisprimarilyattributedtothewidespreadavailabilityofgenericdrugsinemergingmarketsandthegrowingprevalenceofchronicdiseasesworldwide .
Scope Of The Report
Report Attributes
Report Details
Report Title
Biotechnology/Pharmaceutical Services Outsourcing Market Research Report
By Type
Consulting, Auditing & Assessment, Regulatory Affairs, Product Maintenance, Product Design & Development, Product Testing & Validation, Training & Education, Others
By Application
Regenerative Medicine, Biobanking, Drug Discovery
By Companies
Quantic Group, QuintilesIMS, Parexel International Corporation, Lachman Associates, GMP Pharmaceuticals, Management Forum, Quality Context, Inspired Pharma, Concept Heidelberg GmbH, RSSL
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Biotechnology/Pharmaceutical Services Outsourcing Market Report Segments:
The global Biotechnology/Pharmaceutical Services Outsourcing market is segmented on the basis of:
Types
Consulting, Auditing & Assessment, Regulatory Affairs, Product Maintenance, Product Design & Development, Product Testing & Validation, Training & Education, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Regenerative Medicine, Biobanking, Drug Discovery
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Quantic Group
- QuintilesIMS
- Parexel International Corporation
- Lachman Associates
- GMP Pharmaceuticals
- Management Forum
- Quality Context
- Inspired Pharma
- Concept Heidelberg GmbH
- RSSL
Highlights of The Biotechnology/Pharmaceutical Services Outsourcing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Consulting
- Auditing & Assessment
- Regulatory Affairs
- Product Maintenance
- Product Design & Development
- Product Testing & Validation
- Training & Education
- Others
- By Application:
- Regenerative Medicine
- Biobanking
- Drug Discovery
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biotechnology/Pharmaceutical Services Outsourcing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Biotechnology/Pharmaceutical Services Outsourcing is the process of contracting with a third-party company to provide specialized services in the field of biotechnology and pharmaceuticals. These companies can provide a wide range of services, including research and development, manufacturing, marketing, and distribution.
Some of the major players in the biotechnology/pharmaceutical services outsourcing market are Quantic Group, QuintilesIMS, Parexel International Corporation, Lachman Associates, GMP Pharmaceuticals, Management Forum, Quality Context, Inspired Pharma, Concept Heidelberg GmbH, RSSL.
The biotechnology/pharmaceutical services outsourcing market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biotechnology/Pharmaceutical Services Outsourcing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biotechnology/Pharmaceutical Services Outsourcing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biotechnology/Pharmaceutical Services Outsourcing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biotechnology/Pharmaceutical Services Outsourcing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biotechnology/Pharmaceutical Services Outsourcing Market Size & Forecast, 2018-2028
4.5.1 Biotechnology/Pharmaceutical Services Outsourcing Market Size and Y-o-Y Growth
4.5.2 Biotechnology/Pharmaceutical Services Outsourcing Market Absolute $ Opportunity
Chapter 5 Global Biotechnology/Pharmaceutical Services Outsourcing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Type
5.2.1 Consulting
5.2.2 Auditing & Assessment
5.2.3 Regulatory Affairs
5.2.4 Product Maintenance
5.2.5 Product Design & Development
5.2.6 Product Testing & Validation
5.2.7 Training & Education
5.2.8 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Biotechnology/Pharmaceutical Services Outsourcing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Applications
6.2.1 Regenerative Medicine
6.2.2 Biobanking
6.2.3 Drug Discovery
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biotechnology/Pharmaceutical Services Outsourcing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Biotechnology/Pharmaceutical Services Outsourcing Analysis and Forecast
9.1 Introduction
9.2 North America Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Type
9.6.1 Consulting
9.6.2 Auditing & Assessment
9.6.3 Regulatory Affairs
9.6.4 Product Maintenance
9.6.5 Product Design & Development
9.6.6 Product Testing & Validation
9.6.7 Training & Education
9.6.8 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Applications
9.10.1 Regenerative Medicine
9.10.2 Biobanking
9.10.3 Drug Discovery
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Biotechnology/Pharmaceutical Services Outsourcing Analysis and Forecast
10.1 Introduction
10.2 Europe Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Type
10.6.1 Consulting
10.6.2 Auditing & Assessment
10.6.3 Regulatory Affairs
10.6.4 Product Maintenance
10.6.5 Product Design & Development
10.6.6 Product Testing & Validation
10.6.7 Training & Education
10.6.8 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Applications
10.10.1 Regenerative Medicine
10.10.2 Biobanking
10.10.3 Drug Discovery
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Biotechnology/Pharmaceutical Services Outsourcing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Type
11.6.1 Consulting
11.6.2 Auditing & Assessment
11.6.3 Regulatory Affairs
11.6.4 Product Maintenance
11.6.5 Product Design & Development
11.6.6 Product Testing & Validation
11.6.7 Training & Education
11.6.8 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Applications
11.10.1 Regenerative Medicine
11.10.2 Biobanking
11.10.3 Drug Discovery
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Biotechnology/Pharmaceutical Services Outsourcing Analysis and Forecast
12.1 Introduction
12.2 Latin America Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Type
12.6.1 Consulting
12.6.2 Auditing & Assessment
12.6.3 Regulatory Affairs
12.6.4 Product Maintenance
12.6.5 Product Design & Development
12.6.6 Product Testing & Validation
12.6.7 Training & Education
12.6.8 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Applications
12.10.1 Regenerative Medicine
12.10.2 Biobanking
12.10.3 Drug Discovery
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Biotechnology/Pharmaceutical Services Outsourcing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Type
13.6.1 Consulting
13.6.2 Auditing & Assessment
13.6.3 Regulatory Affairs
13.6.4 Product Maintenance
13.6.5 Product Design & Development
13.6.6 Product Testing & Validation
13.6.7 Training & Education
13.6.8 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Biotechnology/Pharmaceutical Services Outsourcing Market Size Forecast by Applications
13.10.1 Regenerative Medicine
13.10.2 Biobanking
13.10.3 Drug Discovery
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biotechnology/Pharmaceutical Services Outsourcing Market: Competitive Dashboard
14.2 Global Biotechnology/Pharmaceutical Services Outsourcing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Quantic Group
14.3.2 QuintilesIMS
14.3.3 Parexel International Corporation
14.3.4 Lachman Associates
14.3.5 GMP Pharmaceuticals
14.3.6 Management Forum
14.3.7 Quality Context
14.3.8 Inspired Pharma
14.3.9 Concept Heidelberg GmbH
14.3.10 RSSL
